Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stroke prevention by statins].

Naoki Sawada1, Hiroshi Itoh, Kazuwa Nakao

  • 1Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgery for gastric cancer patients of age 85 and older: Multicenter survey.

World journal of gastroenterology·2017
Same author

L-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patients.

Bioscience of microbiota, food and health·2017
Same author

Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD.

Journal of atherosclerosis and thrombosis·2017
Same author

Clinical significance of 'cardiometabolic memory': a systematic review of randomized controlled trials.

Hypertension research : official journal of the Japanese Society of Hypertension·2017
Same author

Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy.

JCI insight·2017
Same author

Expression of epithelial cell-derived cytokine genes in the duodenal and colonic mucosae of dogs with chronic enteropathy.

The Journal of veterinary medical science·2017

Statins, or HMG-CoA reductase inhibitors, significantly reduce stroke risk by 20-30%, particularly for thromboembolic events. Their benefits extend beyond lipid lowering, showing promise for high-risk patients, including the elderly.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Context:

  • The link between serum lipid levels and stroke incidence remains unclear.
  • Traditional lipid-lowering drugs like fibrates have not proven effective for stroke prevention.

Purpose:

  • To evaluate the efficacy and safety of HMG-CoA reductase inhibitors (statins) in stroke prevention.
  • To explore the mechanisms behind statin's beneficial effects on cerebrovascular events.

Summary:

  • Clinical trials show statins reduce cerebrovascular event risk by 20-30% in patients with prior coronary heart disease (CHD).
  • The benefit is most pronounced for thromboembolic stroke, with no increase in hemorrhagic events.
  • Statins demonstrate efficacy in both hyper- and normocholesterolemic individuals, suggesting non-lipid-lowering mechanisms.

Related Experiment Videos

Impact:

  • Statin therapy is a promising strategy for managing stroke risk in high-risk populations, including elderly patients with or without CHD.
  • This highlights the potential of statins for broader cardiovascular and cerebrovascular risk reduction.